Navigation Links
AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
Date:6/29/2009

>

Study investigator, anesthesiologist Dr. Neil Singla, CEO of Lotus Clinical Research Inc., Pasadena, CA, stated, "The ARX-01 product has the potential to offer a major advance in the management of inpatient acute pain, liberating patients from the IV connection to a PCA pump, while still providing effective pain control appropriate even for patients who are restricted from oral medication. Patients appear to tolerate the Sufentanil NanoTabs well, and following the end of the 12-hour study period when they were switched to IV PCA morphine, many requested that they be returned to study drug. To me, these patients' requests are as demonstrative as any more quantitative endpoint of the product's advantages from the patient perspective."

The current data support the previously reported positive results for ARX-01 from the first Phase 2 study which evaluated the safety and efficacy of ARX-01 Sufentanil NanoTabs in patients undergoing elective unilateral knee replacement surgery. Additionally, an open-label Phase 2 study is currently ongoing with the primary objective of assessing the functionality of the handheld device component of the ARX-01 Sufentanil NanoTab PCA System in patients undergoing unilateral knee replacement surgery.

AcelRx Chief Medical Officer, Pamela Palmer, M.D., Ph.D., commented, "The Phase 2 results from both knee replacement and major abdominal surgery studies demonstrate that a wide variety of patients experiencing moderate-to-severe post-operative pain are able to achieve significant pain relief with our non-invasive approach to patient-controlled analgesia utilizing sublingual Sufentanil NanoTabs. We are pleased with the efficacy results, as well as with the overall side-effect profile of ARX-01 which was indistinguishable from placebo in both studies."

About Acute Post-Operative Pain

Annually, approximately 8 million patients in the U.S. receive intravenous (IV) patient-cont
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
2. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Calif. , Aug. 3, 2015  CytomX, ... treatment of cancer, today announced the promotion of ... Debanjan Ray , who previously served as ... has been promoted to senior vice president of ... Mr. Ray held positions as the vice president ...
(Date:8/3/2015)...  Celsion Corporation (NASDAQ: CLSN ) announced ... call to discuss its second quarter 2015 financial ... programs for ThermoDox®, its proprietary heat-activated liposomal encapsulation ... TheraPlas™ and TheraSilence™, in immunotherapy and RNA delivery ... 2015. To participate in the call, interested parties ...
(Date:8/3/2015)... 3, 2015 Immune Pharmaceuticals, Inc. ("Immune") (NASDAQ: ... Daniel Teper , will present live at VirtualInvestorConferences.com on ... TIME:   11:30AM EDT LINK:    http://tinyurl.com/aug6-pre-imnp ... event where investors are invited to ask the company ... as well as the association,s "virtual trade booth." If ...
Breaking Medicine Technology:CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2
... Still River Systems, Inc. announces today that ... with the Massachusetts Institute of Technology (M.I.T.) to ... Plasma Science and Fusion Center in collaboration with ... in conjunction with its own leading-edge developments in ...
... Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ... services to customers located in 85 countries, today announced ... manufacture at the 22nd American Peptide Symposium to be ... "It is fitting that we formally launch our ...
Cached Medicine Technology:Still River Systems Sign Patent License Agreement With the Massachusetts Institute of Technology 2Neuland Labs Launches Expanded Peptide Manufacturing Capabilities at 22nd American Peptide Symposium 2Neuland Labs Launches Expanded Peptide Manufacturing Capabilities at 22nd American Peptide Symposium 3
(Date:8/4/2015)... ... August 04, 2015 , ... ... learning, announced today that its RN to BSN and Master of Science ... full accreditation through June 2020 from the Commission on Collegiate Nursing Education ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... state-of-the-art digital press at its Denver facility that will usher in a new ... help Lightning Labels more effectively meet its twin objectives of quality ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... their partnership to make the Isabel Symptom Checker available to all users of ... a mechanism to check their symptoms in an easy, intuitive method, provides access ...
(Date:8/3/2015)... ... August 04, 2015 , ... The American Academy ... The new internationally peer-reviewed Guidelines were prepared by members of the AAT as ... in evaluating patients with dental-oral and systemic health-related complaints. , Thermography is ...
(Date:8/3/2015)... ... August 03, 2015 , ... Representatives with Health ... on its website. , “Our ‘Ask a Nutritionist’ feature on our website is a ... healthily,” said Liza Brisk, nutritionist and spokeswoman for Health Food Grocers. , Health Food ...
Breaking Medicine News(10 mins):Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 3Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 4Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3Health News:American Academy of Thermology (AAT) Publishes First-Ever Guidelines for Oral-Systemic Thermography 2Health News:American Academy of Thermology (AAT) Publishes First-Ever Guidelines for Oral-Systemic Thermography 3Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 2Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 3
... HealthTransaction Network(R) keeps costs down and improves access ... connecting health care facilities ... HealthTransaction Network(R) is,creating the first-ever nationwide health care ... services to underserved populations at,affordable costs, the company ...
... prevalence of congenital heart disease (CHD) among in vitro ... general population, but there is an increasing risk of ... by Yale School of Medicine researchers. , Mert ... Obstetrics, Gynecology & Reproductive Sciences, will present the abstract ...
... Results and Enables Resident Care Teams to Boost Time with ... ... 31 Vocollect Healthcare Systems, Inc.,the leading provider of voice-assisted care, ... has,completed its enterprise-wide implementation of AccuNurse voice-assisted,care at all four of ...
... with a chronic disease or cancer have to contend ... anemia impedes the patient considerably in his or her ... to a large number of these patients to alleviate ... always effective, and not all patients respond to this ...
... Tigris Pharmaceuticals,Inc., a privately held drug development company, ... to its Board of Directors., Mr. Granadillo served ... until 2004 when he retired after 34 years of ... comprised of its top,seven executives. As Lilly,s top human ...
... 31 A scary question indeed.,We,re not talking about ... or First Aid, or even the Emergency Room physician ... the people who do the education,training and research and ... your life. Most research makes the average person,s head ...
Cached Medicine News:Health News:Buffalo Company Launches First-ever National Electronic Transaction Network to Improve Health Care Access for Uninsured and Underinsured 2Health News:Buffalo Company Launches First-ever National Electronic Transaction Network to Improve Health Care Access for Uninsured and Underinsured 3Health News:Congenital heart defects increasing among IVF twins 2Health News:Peninsula United Methodist Homes Completes Enterprise-Wide Deployment of AccuNurse Voice-Assisted Care 2Health News:Peninsula United Methodist Homes Completes Enterprise-Wide Deployment of AccuNurse Voice-Assisted Care 3Health News:Progress toward an alternative for EPO: Gas6 offers remedy where EPO fails today 2Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 2Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 3Health News:Who Decides How to Save Your Life? 2
... The Nidek's ophthalmic Nd: YAG laser ... featured system of superb versatility and clinical ... YAG Laser (1064nm),, Lightweight Model ,Further ... more convenient setting in your office.,, ...
... delivers a solid-state green laser ... and plugs into any standard ... and extreme portability, the unit ... Nidek Phaco Emulsification System CV-24000 ...
... technology is an effective angina ... with poor targets. Because it ... suites, the CO2 Heart Laser ... make timely operative decisions to ...
Ultrasensitive TSH EIA Thyroid Function 025-BC-1003...
Medicine Products: